0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tropicamide Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-16L8313
Home | Market Reports | Health| Pharmacy
Global Tropicamide Market Insights Forecast to 2028
BUY CHAPTERS

Global Tropicamide Market Research Report 2025

Code: QYRE-Auto-16L8313
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tropicamide Market Size

The global market for Tropicamide was valued at US$ 3920 million in the year 2024 and is projected to reach a revised size of US$ 5311 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Tropicamide Market

Tropicamide Market

Tropicamide, sold under the brand name Mydriacyl among others, is a medication used to dilate the pupil and help with examination of the eye. Specifically it is used to help examine the back of the eye. It is applied as eye drops. Effects occur within 40 minutes and last for up to a day.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tropicamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tropicamide.
The Tropicamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tropicamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tropicamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tropicamide Market Report

Report Metric Details
Report Name Tropicamide Market
Accounted market size in year US$ 3920 million
Forecasted market size in 2031 US$ 5311 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 5mg
  • 10mg
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers, Thea Pharma, Vega Pharma, Agepha Pharma, Pharma Stulln, Visufarma, Unimed Pharma, Edol, Polfa Warszawa, Laboratorios Sophia, Nippon Tenganyaku Kenkyujo, Wakamoto, Chauvin Ankerpharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tropicamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tropicamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tropicamide Market growing?

Ans: The Tropicamide Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Tropicamide Market size in 2031?

Ans: The Tropicamide Market size in 2031 will be US$ 5311 million.

Who are the main players in the Tropicamide Market report?

Ans: The main players in the Tropicamide Market are Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers, Thea Pharma, Vega Pharma, Agepha Pharma, Pharma Stulln, Visufarma, Unimed Pharma, Edol, Polfa Warszawa, Laboratorios Sophia, Nippon Tenganyaku Kenkyujo, Wakamoto, Chauvin Ankerpharm

What are the Application segmentation covered in the Tropicamide Market report?

Ans: The Applications covered in the Tropicamide Market report are Hospital, Drug Store

What are the Type segmentation covered in the Tropicamide Market report?

Ans: The Types covered in the Tropicamide Market report are 5mg, 10mg

Recommended Reports

Ophthalmic Drugs

Related Eyecare

Pharmaceutical Actives

1 Tropicamide Market Overview
1.1 Product Definition
1.2 Tropicamide by Type
1.2.1 Global Tropicamide Market Value Comparison by Type (2024 VS 2031)
1.2.2 5mg
1.2.3 10mg
1.3 Tropicamide by Application
1.3.1 Global Tropicamide Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Tropicamide Market Size Estimates and Forecasts
1.4.1 Global Tropicamide Revenue 2020-2031
1.4.2 Global Tropicamide Sales 2020-2031
1.4.3 Global Tropicamide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tropicamide Market Competition by Manufacturers
2.1 Global Tropicamide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tropicamide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tropicamide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tropicamide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tropicamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tropicamide, Product Type & Application
2.7 Global Key Manufacturers of Tropicamide, Date of Enter into This Industry
2.8 Global Tropicamide Market Competitive Situation and Trends
2.8.1 Global Tropicamide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tropicamide Players Market Share by Revenue
2.8.3 Global Tropicamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tropicamide Market Scenario by Region
3.1 Global Tropicamide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tropicamide Sales by Region: 2020-2031
3.2.1 Global Tropicamide Sales by Region: 2020-2025
3.2.2 Global Tropicamide Sales by Region: 2026-2031
3.3 Global Tropicamide Revenue by Region: 2020-2031
3.3.1 Global Tropicamide Revenue by Region: 2020-2025
3.3.2 Global Tropicamide Revenue by Region: 2026-2031
3.4 North America Tropicamide Market Facts & Figures by Country
3.4.1 North America Tropicamide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tropicamide Sales by Country (2020-2031)
3.4.3 North America Tropicamide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tropicamide Market Facts & Figures by Country
3.5.1 Europe Tropicamide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tropicamide Sales by Country (2020-2031)
3.5.3 Europe Tropicamide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tropicamide Market Facts & Figures by Region
3.6.1 Asia Pacific Tropicamide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tropicamide Sales by Region (2020-2031)
3.6.3 Asia Pacific Tropicamide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tropicamide Market Facts & Figures by Country
3.7.1 Latin America Tropicamide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tropicamide Sales by Country (2020-2031)
3.7.3 Latin America Tropicamide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tropicamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Tropicamide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tropicamide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tropicamide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tropicamide Sales by Type (2020-2031)
4.1.1 Global Tropicamide Sales by Type (2020-2025)
4.1.2 Global Tropicamide Sales by Type (2026-2031)
4.1.3 Global Tropicamide Sales Market Share by Type (2020-2031)
4.2 Global Tropicamide Revenue by Type (2020-2031)
4.2.1 Global Tropicamide Revenue by Type (2020-2025)
4.2.2 Global Tropicamide Revenue by Type (2026-2031)
4.2.3 Global Tropicamide Revenue Market Share by Type (2020-2031)
4.3 Global Tropicamide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tropicamide Sales by Application (2020-2031)
5.1.1 Global Tropicamide Sales by Application (2020-2025)
5.1.2 Global Tropicamide Sales by Application (2026-2031)
5.1.3 Global Tropicamide Sales Market Share by Application (2020-2031)
5.2 Global Tropicamide Revenue by Application (2020-2031)
5.2.1 Global Tropicamide Revenue by Application (2020-2025)
5.2.2 Global Tropicamide Revenue by Application (2026-2031)
5.2.3 Global Tropicamide Revenue Market Share by Application (2020-2031)
5.3 Global Tropicamide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alcon Laboratories
6.1.1 Alcon Laboratories Company Information
6.1.2 Alcon Laboratories Description and Business Overview
6.1.3 Alcon Laboratories Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alcon Laboratories Tropicamide Product Portfolio
6.1.5 Alcon Laboratories Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Company Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Akorn Tropicamide Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Company Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch Health Tropicamide Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Miza Pharmaceuticals
6.4.1 Miza Pharmaceuticals Company Information
6.4.2 Miza Pharmaceuticals Description and Business Overview
6.4.3 Miza Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Miza Pharmaceuticals Tropicamide Product Portfolio
6.4.5 Miza Pharmaceuticals Recent Developments/Updates
6.5 Watson Laboratories
6.5.1 Watson Laboratories Company Information
6.5.2 Watson Laboratories Description and Business Overview
6.5.3 Watson Laboratories Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Watson Laboratories Tropicamide Product Portfolio
6.5.5 Watson Laboratories Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Tropicamide Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Dioptic Pharmaceuticals
6.7.1 Dioptic Pharmaceuticals Company Information
6.7.2 Dioptic Pharmaceuticals Description and Business Overview
6.7.3 Dioptic Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dioptic Pharmaceuticals Tropicamide Product Portfolio
6.7.5 Dioptic Pharmaceuticals Recent Developments/Updates
6.8 Roemmers
6.8.1 Roemmers Company Information
6.8.2 Roemmers Description and Business Overview
6.8.3 Roemmers Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roemmers Tropicamide Product Portfolio
6.8.5 Roemmers Recent Developments/Updates
6.9 Thea Pharma
6.9.1 Thea Pharma Company Information
6.9.2 Thea Pharma Description and Business Overview
6.9.3 Thea Pharma Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Thea Pharma Tropicamide Product Portfolio
6.9.5 Thea Pharma Recent Developments/Updates
6.10 Vega Pharma
6.10.1 Vega Pharma Company Information
6.10.2 Vega Pharma Description and Business Overview
6.10.3 Vega Pharma Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vega Pharma Tropicamide Product Portfolio
6.10.5 Vega Pharma Recent Developments/Updates
6.11 Agepha Pharma
6.11.1 Agepha Pharma Company Information
6.11.2 Agepha Pharma Description and Business Overview
6.11.3 Agepha Pharma Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Agepha Pharma Tropicamide Product Portfolio
6.11.5 Agepha Pharma Recent Developments/Updates
6.12 Pharma Stulln
6.12.1 Pharma Stulln Company Information
6.12.2 Pharma Stulln Description and Business Overview
6.12.3 Pharma Stulln Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pharma Stulln Tropicamide Product Portfolio
6.12.5 Pharma Stulln Recent Developments/Updates
6.13 Visufarma
6.13.1 Visufarma Company Information
6.13.2 Visufarma Description and Business Overview
6.13.3 Visufarma Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Visufarma Tropicamide Product Portfolio
6.13.5 Visufarma Recent Developments/Updates
6.14 Unimed Pharma
6.14.1 Unimed Pharma Company Information
6.14.2 Unimed Pharma Description and Business Overview
6.14.3 Unimed Pharma Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Unimed Pharma Tropicamide Product Portfolio
6.14.5 Unimed Pharma Recent Developments/Updates
6.15 Edol
6.15.1 Edol Company Information
6.15.2 Edol Description and Business Overview
6.15.3 Edol Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Edol Tropicamide Product Portfolio
6.15.5 Edol Recent Developments/Updates
6.16 Polfa Warszawa
6.16.1 Polfa Warszawa Company Information
6.16.2 Polfa Warszawa Description and Business Overview
6.16.3 Polfa Warszawa Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Polfa Warszawa Tropicamide Product Portfolio
6.16.5 Polfa Warszawa Recent Developments/Updates
6.17 Laboratorios Sophia
6.17.1 Laboratorios Sophia Company Information
6.17.2 Laboratorios Sophia Description and Business Overview
6.17.3 Laboratorios Sophia Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Laboratorios Sophia Tropicamide Product Portfolio
6.17.5 Laboratorios Sophia Recent Developments/Updates
6.18 Nippon Tenganyaku Kenkyujo
6.18.1 Nippon Tenganyaku Kenkyujo Company Information
6.18.2 Nippon Tenganyaku Kenkyujo Description and Business Overview
6.18.3 Nippon Tenganyaku Kenkyujo Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio
6.18.5 Nippon Tenganyaku Kenkyujo Recent Developments/Updates
6.19 Wakamoto
6.19.1 Wakamoto Company Information
6.19.2 Wakamoto Description and Business Overview
6.19.3 Wakamoto Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Wakamoto Tropicamide Product Portfolio
6.19.5 Wakamoto Recent Developments/Updates
6.20 Chauvin Ankerpharm
6.20.1 Chauvin Ankerpharm Company Information
6.20.2 Chauvin Ankerpharm Description and Business Overview
6.20.3 Chauvin Ankerpharm Tropicamide Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Chauvin Ankerpharm Tropicamide Product Portfolio
6.20.5 Chauvin Ankerpharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tropicamide Industry Chain Analysis
7.2 Tropicamide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tropicamide Production Mode & Process Analysis
7.4 Tropicamide Sales and Marketing
7.4.1 Tropicamide Sales Channels
7.4.2 Tropicamide Distributors
7.5 Tropicamide Customer Analysis
8 Tropicamide Market Dynamics
8.1 Tropicamide Industry Trends
8.2 Tropicamide Market Drivers
8.3 Tropicamide Market Challenges
8.4 Tropicamide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tropicamide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tropicamide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tropicamide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tropicamide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tropicamide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tropicamide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tropicamide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tropicamide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tropicamide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tropicamide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tropicamide, Product Type & Application
 Table 12. Global Key Manufacturers of Tropicamide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tropicamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tropicamide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tropicamide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tropicamide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tropicamide Sales Market Share by Region (2020-2025)
 Table 19. Global Tropicamide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tropicamide Sales Market Share by Region (2026-2031)
 Table 21. Global Tropicamide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tropicamide Revenue Market Share by Region (2020-2025)
 Table 23. Global Tropicamide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tropicamide Revenue Market Share by Region (2026-2031)
 Table 25. North America Tropicamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tropicamide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tropicamide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tropicamide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tropicamide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tropicamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tropicamide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tropicamide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tropicamide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tropicamide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tropicamide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tropicamide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tropicamide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tropicamide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tropicamide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tropicamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tropicamide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tropicamide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tropicamide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tropicamide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tropicamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tropicamide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tropicamide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tropicamide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tropicamide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tropicamide Sales (K Units) by Type (2020-2025)
 Table 51. Global Tropicamide Sales (K Units) by Type (2026-2031)
 Table 52. Global Tropicamide Sales Market Share by Type (2020-2025)
 Table 53. Global Tropicamide Sales Market Share by Type (2026-2031)
 Table 54. Global Tropicamide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tropicamide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tropicamide Revenue Market Share by Type (2020-2025)
 Table 57. Global Tropicamide Revenue Market Share by Type (2026-2031)
 Table 58. Global Tropicamide Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tropicamide Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tropicamide Sales (K Units) by Application (2020-2025)
 Table 61. Global Tropicamide Sales (K Units) by Application (2026-2031)
 Table 62. Global Tropicamide Sales Market Share by Application (2020-2025)
 Table 63. Global Tropicamide Sales Market Share by Application (2026-2031)
 Table 64. Global Tropicamide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tropicamide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tropicamide Revenue Market Share by Application (2020-2025)
 Table 67. Global Tropicamide Revenue Market Share by Application (2026-2031)
 Table 68. Global Tropicamide Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tropicamide Price (US$/Unit) by Application (2026-2031)
 Table 70. Alcon Laboratories Company Information
 Table 71. Alcon Laboratories Description and Business Overview
 Table 72. Alcon Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Alcon Laboratories Tropicamide Product
 Table 74. Alcon Laboratories Recent Developments/Updates
 Table 75. Akorn Company Information
 Table 76. Akorn Description and Business Overview
 Table 77. Akorn Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Akorn Tropicamide Product
 Table 79. Akorn Recent Developments/Updates
 Table 80. Bausch Health Company Information
 Table 81. Bausch Health Description and Business Overview
 Table 82. Bausch Health Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bausch Health Tropicamide Product
 Table 84. Bausch Health Recent Developments/Updates
 Table 85. Miza Pharmaceuticals Company Information
 Table 86. Miza Pharmaceuticals Description and Business Overview
 Table 87. Miza Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Miza Pharmaceuticals Tropicamide Product
 Table 89. Miza Pharmaceuticals Recent Developments/Updates
 Table 90. Watson Laboratories Company Information
 Table 91. Watson Laboratories Description and Business Overview
 Table 92. Watson Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Watson Laboratories Tropicamide Product
 Table 94. Watson Laboratories Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Tropicamide Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Dioptic Pharmaceuticals Company Information
 Table 101. Dioptic Pharmaceuticals Description and Business Overview
 Table 102. Dioptic Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Dioptic Pharmaceuticals Tropicamide Product
 Table 104. Dioptic Pharmaceuticals Recent Developments/Updates
 Table 105. Roemmers Company Information
 Table 106. Roemmers Description and Business Overview
 Table 107. Roemmers Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Roemmers Tropicamide Product
 Table 109. Roemmers Recent Developments/Updates
 Table 110. Thea Pharma Company Information
 Table 111. Thea Pharma Description and Business Overview
 Table 112. Thea Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Thea Pharma Tropicamide Product
 Table 114. Thea Pharma Recent Developments/Updates
 Table 115. Vega Pharma Company Information
 Table 116. Vega Pharma Description and Business Overview
 Table 117. Vega Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Vega Pharma Tropicamide Product
 Table 119. Vega Pharma Recent Developments/Updates
 Table 120. Agepha Pharma Company Information
 Table 121. Agepha Pharma Description and Business Overview
 Table 122. Agepha Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Agepha Pharma Tropicamide Product
 Table 124. Agepha Pharma Recent Developments/Updates
 Table 125. Pharma Stulln Company Information
 Table 126. Pharma Stulln Description and Business Overview
 Table 127. Pharma Stulln Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Pharma Stulln Tropicamide Product
 Table 129. Pharma Stulln Recent Developments/Updates
 Table 130. Visufarma Company Information
 Table 131. Visufarma Description and Business Overview
 Table 132. Visufarma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Visufarma Tropicamide Product
 Table 134. Visufarma Recent Developments/Updates
 Table 135. Unimed Pharma Company Information
 Table 136. Unimed Pharma Description and Business Overview
 Table 137. Unimed Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Unimed Pharma Tropicamide Product
 Table 139. Unimed Pharma Recent Developments/Updates
 Table 140. Edol Company Information
 Table 141. Edol Description and Business Overview
 Table 142. Edol Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Edol Tropicamide Product
 Table 144. Edol Recent Developments/Updates
 Table 145. Polfa Warszawa Company Information
 Table 146. Polfa Warszawa Description and Business Overview
 Table 147. Polfa Warszawa Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Polfa Warszawa Tropicamide Product
 Table 149. Polfa Warszawa Recent Developments/Updates
 Table 150. Laboratorios Sophia Company Information
 Table 151. Laboratorios Sophia Description and Business Overview
 Table 152. Laboratorios Sophia Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Laboratorios Sophia Tropicamide Product
 Table 154. Laboratorios Sophia Recent Developments/Updates
 Table 155. Nippon Tenganyaku Kenkyujo Company Information
 Table 156. Nippon Tenganyaku Kenkyujo Description and Business Overview
 Table 157. Nippon Tenganyaku Kenkyujo Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Nippon Tenganyaku Kenkyujo Tropicamide Product
 Table 159. Nippon Tenganyaku Kenkyujo Recent Developments/Updates
 Table 160. Wakamoto Company Information
 Table 161. Wakamoto Description and Business Overview
 Table 162. Wakamoto Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Wakamoto Tropicamide Product
 Table 164. Wakamoto Recent Developments/Updates
 Table 165. Chauvin Ankerpharm Company Information
 Table 166. Chauvin Ankerpharm Description and Business Overview
 Table 167. Chauvin Ankerpharm Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Chauvin Ankerpharm Tropicamide Product
 Table 169. Chauvin Ankerpharm Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Tropicamide Distributors List
 Table 173. Tropicamide Customers List
 Table 174. Tropicamide Market Trends
 Table 175. Tropicamide Market Drivers
 Table 176. Tropicamide Market Challenges
 Table 177. Tropicamide Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tropicamide
 Figure 2. Global Tropicamide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tropicamide Market Share by Type: 2024 & 2031
 Figure 4. 5mg Product Picture
 Figure 5. 10mg Product Picture
 Figure 6. Global Tropicamide Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tropicamide Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. Global Tropicamide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Tropicamide Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Tropicamide Sales (2020-2031) & (K Units)
 Figure 13. Global Tropicamide Average Price (US$/Unit) & (2020-2031)
 Figure 14. Tropicamide Report Years Considered
 Figure 15. Tropicamide Sales Share by Manufacturers in 2024
 Figure 16. Global Tropicamide Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Tropicamide Players: Market Share by Revenue in Tropicamide in 2024
 Figure 18. Tropicamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Tropicamide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Tropicamide Sales Market Share by Country (2020-2031)
 Figure 21. North America Tropicamide Revenue Market Share by Country (2020-2031)
 Figure 22. United States Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Tropicamide Sales Market Share by Country (2020-2031)
 Figure 25. Europe Tropicamide Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Tropicamide Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Tropicamide Revenue Market Share by Region (2020-2031)
 Figure 33. China Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Tropicamide Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Tropicamide Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Tropicamide Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Tropicamide Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Tropicamide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Tropicamide by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Tropicamide by Type (2020-2031)
 Figure 54. Global Tropicamide Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Tropicamide by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Tropicamide by Application (2020-2031)
 Figure 57. Global Tropicamide Price (US$/Unit) by Application (2020-2031)
 Figure 58. Tropicamide Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart